1. Home
  2. CNTA vs ACLS Comparison

CNTA vs ACLS Comparison

Compare CNTA & ACLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CNTA
  • ACLS
  • Stock Information
  • Founded
  • CNTA 2020
  • ACLS 1995
  • Country
  • CNTA United Kingdom
  • ACLS United States
  • Employees
  • CNTA N/A
  • ACLS N/A
  • Industry
  • CNTA Biotechnology: Pharmaceutical Preparations
  • ACLS Industrial Machinery/Components
  • Sector
  • CNTA Health Care
  • ACLS Technology
  • Exchange
  • CNTA Nasdaq
  • ACLS Nasdaq
  • Market Cap
  • CNTA 1.8B
  • ACLS 1.5B
  • IPO Year
  • CNTA 2021
  • ACLS 2000
  • Fundamental
  • Price
  • CNTA $12.30
  • ACLS $57.66
  • Analyst Decision
  • CNTA Strong Buy
  • ACLS Buy
  • Analyst Count
  • CNTA 10
  • ACLS 7
  • Target Price
  • CNTA $26.11
  • ACLS $133.00
  • AVG Volume (30 Days)
  • CNTA 617.5K
  • ACLS 653.6K
  • Earning Date
  • CNTA 05-20-2025
  • ACLS 05-06-2025
  • Dividend Yield
  • CNTA N/A
  • ACLS N/A
  • EPS Growth
  • CNTA N/A
  • ACLS N/A
  • EPS
  • CNTA N/A
  • ACLS 5.46
  • Revenue
  • CNTA N/A
  • ACLS $958,056,000.00
  • Revenue This Year
  • CNTA N/A
  • ACLS N/A
  • Revenue Next Year
  • CNTA N/A
  • ACLS $10.57
  • P/E Ratio
  • CNTA N/A
  • ACLS $10.53
  • Revenue Growth
  • CNTA N/A
  • ACLS N/A
  • 52 Week Low
  • CNTA $7.75
  • ACLS $40.40
  • 52 Week High
  • CNTA $19.09
  • ACLS $158.61
  • Technical
  • Relative Strength Index (RSI)
  • CNTA 40.97
  • ACLS 64.91
  • Support Level
  • CNTA $11.88
  • ACLS $46.52
  • Resistance Level
  • CNTA $14.39
  • ACLS $60.37
  • Average True Range (ATR)
  • CNTA 0.79
  • ACLS 2.73
  • MACD
  • CNTA -0.00
  • ACLS 1.58
  • Stochastic Oscillator
  • CNTA 18.68
  • ACLS 83.36

About CNTA Centessa Pharmaceuticals plc

Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.

About ACLS Axcelis Technologies Inc.

Axcelis Technologies Inc designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips. In addition to equipment, the company provides aftermarket lifecycle products and services, including used tools, spare parts, equipment upgrades, maintenance services, and customer training. Geographically, the group has a business presence in North America, Asia Pacific, and Europe, of which key revenue is derived from the Asia Pacific.

Share on Social Networks: